A new Microfluidic Chip technology raised €1.9Million
Lunaphore Technologies closed a Series A financing round of €1.9M (CHF 2 millions). The round…
Lunaphore Technologies closed a Series A financing round of €1.9M (CHF 2 millions). The round…
Last Monday, Belgian Biocartis launched an IPO that quickly raised €100M; the offering was closed…
Cytena and its cy-Clone device to separate single cells received €1.1M from a consortium made…
Last week, the European Commission approved 19 GMOs, the first authorizations since 2013. Shortly after,…
Finland-based Biotie Therapies will receive an investment of more than €92M from Baupost group. However, the…
France-based PEP-Therapy has raised €1.3M in initial funding. This sum, invested by the Quadrivium 1…
The Biosimilar drug field is growing fast despite the tight regulatory, business and financial challenges it…
How do you manage a planet with a growing population with increasing consumption needs when you only have a limited…
Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the…
Novo Nordisk, the Danish global healthcare company, received the all clear a few month ago from the…
Dr. Andrei Popov, CEO at Ecrins Therapeutics Photo credit: Ecrins Therapeutics Laureate of the 2002…
Results from a new global survey of lung cancer oncologists have shown that, despite 81%…